Curaxis Pharmaceutical Corp
SEC CIK 1434893 · CURX.PK · last insider filing 2012-05-10
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Wright Timothy R | Director · Interim CEO | filed 2011 - 2012 |
| Gothner K Ivan F | Director | filed 2011 - 2012 |
| George Michael W | Director | filed 2011 - 2012 |
| Novak Terence | Director | filed 2011 - 2012 |
| Leary Stephen J | Director | filed 2011 - 2012 |
| Smith Patrick S | Director · Chief Executive Officer | filed 2010 - 2011 |
| Spilker Bert | Director | filed 2010 - 2011 |
| Miller Michael R | Director | filed 2011 - 2011 |
| Mcconville William E | Director | filed 2010 - 2010 |
| Goldberg Sheldon L | Director | filed 2010 - 2010 |
| Corcoran David J | Director · Chief Financial Officer | filed 2010 - 2010 |
| Pompeo Ronald V | Director | filed 2010 - 2010 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Geaslen Judith S.T. | Vice President - Finance | filed 2010 - 2012 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.